Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of Sublingual Birch Pollen Extract (AL0206st)
NCT00818181Phase 2Completed
- Sponsor
- Allergopharma
- Start
- Jun 2008
- Primary completion
- Feb 2009
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of allergenic extract of birch in allergic rhinoconjunctivitis (ARC), sponsored by Allergopharma. Started Jun 2008; status: completed.
02
Drugs
allergenic extract of birch
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00818181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818181.